RITEDOSE CORP FDA Approval ANDA 075693

ANDA 075693

RITEDOSE CORP

FDA Drug Application

Application #075693

Documents

Letter2001-01-26

Application Sponsors

ANDA 075693RITEDOSE CORP

Marketing Status

Prescription001

Application Products

001SOLUTION;INHALATION0.02%0IPRATROPIUM BROMIDEIPRATROPIUM BROMIDE

FDA Submissions

ORIG1AP2001-01-26
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2002-04-24
MANUF (CMC); Manufacturing (CMC)SUPPL3AP2002-05-07
MANUF (CMC); Manufacturing (CMC)SUPPL4AP2002-12-17
LABELING; LabelingSUPPL15AP2011-10-21
LABELING; LabelingSUPPL21AP2013-05-20STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL15Null15
SUPPL21Null15

TE Codes

001PrescriptionAN

CDER Filings

RITEDOSE CORP
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 75693
            [companyName] => RITEDOSE CORP
            [docInserts] => ["",""]
            [products] => [{"drugName":"IPRATROPIUM BROMIDE","activeIngredients":"IPRATROPIUM BROMIDE","strength":"0.02%","dosageForm":"SOLUTION;INHALATION","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"IPRATROPIUM BROMIDE","submission":"IPRATROPIUM BROMIDE","actionType":"0.02%","submissionClassification":"SOLUTION;INHALATION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.